STIPPLE BIO
Live / Applied — Second extension granted (statement of use) (as of 10 Sept 2026)
What this means for you
Not registered yet, but its 18 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98910165
- Mark type
- Stylized text
- Filed
- 18 Dec 2024
- Published for opposition
- 05 Aug 2025
- Attorney of record
- Patricia A. Olosky
Goods and services
- Class 005 — Pharmaceuticals: Biological and pharmaceutical preparations for the treatment of cancer and of immune system related diseases and disorders
- Class 042 — Scientific and technological services: Research and development in the field of biotechnology; Pharmaceutical research and development
Owner
- Stipple Bio, Inc., Cambridge, MA, US
- Stipple Bio, Inc., Cambridge, MA, US
Prosecution history
- 11 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2026 — SOU EXTENSION 2 GRANTED
- 10 Sept 2026 — SOU EXTENSION 2 FILED
- 10 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Mar 2026 — SOU EXTENSION 1 GRANTED
- 03 Mar 2026 — SOU EXTENSION 1 FILED
- 03 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Aug 2025 — PUBLISHED FOR OPPOSITION
- 30 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE